Page 504 - Basic _ Clinical Pharmacology ( PDFDrive )

490 SECTION V Drugs That Act in the Central Nervous System

PREP AR A TIONS Lien CA et al: Fumarates: Unique nondepolarizing neuromuscular blocking agents
that are antagonized by cysteine. J Crit Care 2009;24:50.
A V AIL ABLE Llauradó S et al: Sugammadex ideal body weight dose adjusted by level of
neuromuscular blockade in laparoscopic bariatric surgery. Anesthesiology
2012;117:93.
GENERIC NAME AVAILABLE AS Mace SE: Challenges and advances in intubation: Rapid sequence intubation.
NEUROMUSCULAR BLOCKING DRUGS Emerg Med Clin North Am 2008;26:1043.
Atracurium Generic Marshall CG, Ogden DC, Colquhoun D: The actions of suxamethonium (suc-
Cisatracurium Generic, Nimbex cinyldicholine) as an agonist and channel blocker at the nicotinic receptor of
frog muscle. J Physiol (Lond) 1990;428:155.
Pancuronium Generic Martyn JA: Neuromuscular physiology and pharmacology. In: Miller RD (editor):
Rocuronium Generic, Zemuron Anesthesia, 7th ed. Churchill Livingstone, 2010.
Succinylcholine Generic, Anectine, Quelicin Meakin GH: Recent advances in myorelaxant therapy. Paed Anaesthesia
Tubocurarine Generic 2001;11:523.
Vecuronium Generic, Norcuron Murphy GS, Brull SJ: Residual neuromuscular block: Lessons unlearned. Part I:
REVERSAL AGENTS Definitions, incidence, and adverse physiologic effects of residual neuromus-
cular block. Anesth Analg 2010;111:120.
Neostigmine Generic Naguib M: Sugammadex: Another milestone in clinical neuromuscular pharma-
Edrophonium Generic cology. Anesth Analg 2007;104:575.
Sugammadex Bridion Naguib M, Brull SJ: Update on neuromuscular pharmacology. Curr Opin Anaes-
SPASMOLYTICS, ANTISPASMODICS thesiol 2009;22:483.
Baclofen Generic, Lioresal, Gablofen Naguib M, Kopman AF, Ensor JE: Neuromuscular monitoring and postoperative
residual curarisation: A meta-analysis. Br J Anaesth 2007;98:302.
Botulinum toxin type A Botox, Dysport, Xeomin Naguib M et al: Advances in neurobiology of the neuromuscular junction: Impli-
Botulinum toxin type B Myobloc cations for the anesthesiologist. Anesthesiology 2002;96:202.
Carisoprodol Generic, Soma, Vanadom Nicholson WT, Sprung J, Jankowski CJ: Sugammadex: A novel agent for the rever-
sal of neuromuscular blockade. Pharmacotherapy 2007;27:1181.
Chlorzoxazone Generic Pavlin JD, Kent CD: Recovery after ambulatory anesthesia. Curr Opin Anaesthe-
Cyclobenzaprine Generic, Amrix, Fexmid, Flexeril siol 2008;21:729.
Dantrolene Generic, Dantrium, Revonto Puhringer FK et al: Reversal of profound, high-dose rocuronium-induced neuro-
Diazepam Generic, Valium, Diastat muscular blockade by sugammadex at two different time points. Anesthesiol-
Gabapentin Generic, Neurontin, Gabarone ogy 2008;109:188.
Note: This drug is labeled for use only in epilepsy and postherpetic Sacan O, Klein K, White PF: Sugammadex reversal of rocuronium-induced neu-
romuscular blockade: A comparison with neostigmine-glycopyrrolate and
neuralgia. edrophonium-atropine. Anesth Analg 2007;104:569.
Metaxalone Generic, Skelaxin Savarese JJ et al: Preclinical pharmacology of GW280430A (AV430A) in the rhesus
Methocarbamol Generic, Robaxin monkey and in the cat: A comparison with mivacurium. Anesthesiology
Orphenadrine Generic, Norflex, others 2004;100:835.
Riluzole Generic, Rilutek Sine SM: End-plate acetylcholine receptor: Structure, mechanism, pharmacology,
and disease. Physiol Rev 2012;92:1189.
Note: This drug is labeled only for use in amyotrophic lateral sclerosis. Staals LM et al: Reduced clearance of rocuronium and sugammadex in patients
Tizanidine Generic, Zanaflex with severe to end-stage renal failure: A pharmacokinetic study. Br J Anaesth
2010;104:31.
Sugammadex: BRIDION (sugammadex) Injection, for intravenous use initial U.S.
Approval: 2015. Retrieved from http://www.accessdata.fda.gov/drugsatfda_docs/
label/2015/022225lbl.pdf.
REFERENCES Sunaga H et al: Gantacurium and CW002 do not potentiate muscarinic receptor-
Neuromuscular Blockers mediated airway smooth muscle constriction in guinea pigs. Anesthesiology
2010;112:892.
Belmont MR et al: Clinical pharmacology of GW280430A in humans. Anesthe- Viby-Mogensen J: Neuromuscular monitoring. In: Miller RD (editor): Anesthesia,
siology 2004;100:768. 5th ed. Churchill Livingstone, 2000.
Brull SJ, Murphy GS: Residual neuromuscular block: Lessons unlearned.
Part II: Methods to reduce the risk of residual weakness. Anesth Analg Spasmolytics
2010;111:129.
De Boer HD et al: Reversal of rocuronium-induced (1.2 mg/kg) profound neuro- Caron E, Morgan R, Wheless JW: An unusual cause of flaccid paralysis and coma:
muscular blockade by sugammadex. Anesthesiology 2007;107:239. Baclofen overdose. J Child Neurol 2014;29:555.
Gibb AJ, Marshall IG: Pre- and postjunctional effects of tubocurarine and other Corcia P, Meininger V: Management of amyotrophic lateral sclerosis. Drugs
nicotinic antagonists during repetitive stimulation in the rat. J Physiol 2008;68:1037.
1984;351:275. Cutter NC et al: Gabapentin effect on spasticity in multiple sclerosis: A placebo-
Hemmerling TM, Russo G, Bracco D: Neuromuscular blockade in cardiac sur- controlled, randomized trial. Arch Phys Med Rehabil 2000;81:164.
gery: An update for clinicians. Ann Card Anaesth 2008;11:80. Draulans N et al: Intrathecal baclofen in multiple sclerosis and spinal cord injury:
Hirsch NP: Neuromuscular junction in health and disease. Br J Anaesth Complications and long-term dosage evolution. Clin Rehabil 2013;27:1137.
2007;99:132. Frydrych V, Oderda G: Skeletal muscle relaxants drug class review: University of
Kampe S et al: Muscle relaxants. Best Prac Res Clin Anesthesiol 2003;17:137. Utah College of Pharmacy. Final Report 2016. Retrieved from https://www.
Lee C: Structure, conformation, and action of neuromuscular blocking drugs. Br medicaid.utah.gov/pharmacy/.
J Anaesth 2001;87:755. Gracies JM, Singer BJ, Dunne JW: The role of botulinum toxin injections in
Lee C et al: Reversal of profound neuromuscular block by sugammadex adminis- the management of muscle overactivity of the lower limb. Disabil Rehabil
2007;29:1789.
tered three minutes after rocuronium. Anesthesiology 2009;110:1020.